Raymond Nims RMC Pharmaceutical SolutionsRaymond Nims brings over 37 years of experience in the biomedical sciences. He currently provides consulting services as an employee of RMC Pharmaceutical Solutions. From 2006 to 2009, Ray served in Amgen’s corporate Quality Control group, providing subject matter expertise in viral and mycoplasma testing of raw materials and products, and serving as business process owner for Amgen’s global contract analytical testing lab outsourcing program. From 1994 to 2006, Ray directed laboratories at BioReliance performing viral safety, endotoxin, and cell line identity studies for biologics cell line characterization, raw material testing, and product lot release testing. From 1985 to 1994, Ray served as a chemist at the National Cancer Institutes’ Laboratory of Chemical Carcinogenesis, and from 1974 to 1985 Ray held a variety of technical and supervisory positions at Microbiological Associates, a contract research organization. Raymond obtained a PhD in chemistry (chemical toxicology) at The American University, Washington, DC, in 1993. He currently serves on the editorial boards for the International Journal of Toxicology and the BioProcessing Journal, and has served on the ad hoc advisory boards for USP chapters 1237, 1050, and 1050.1. He is a generalist in the biomedical sciences, with a publication list spanning a wide range of areas in chemistry, carcinogenesis, biochemistry, pharmacology, toxicology, and virology.